BERKELEY, Calif., Nov. 20, 2012 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA) today announced the 837-patient Phase 3 PATH trial (Perindopril Amlodipine for the Treatment of Hypertension) has ...

To evaluate the persistence of the antihypertensive effect of perindopril 4 mg+indapamide 1.25 mg once daily for up to 72 h using the ‘missed-dose’ technique. Hypertensive patients were ...

All patients assigned to active treatment received 4 mg of perindopril daily, with indapamide (2.5 mg daily) added at the discretion of the treating physician.

In the perindopril trials, it should be noted that another antihypertensive medication with a proven ability to reduce morbidity and mortality (amlodipine in ASCOT-BPLA and indapamide in ADVANCE ...

Among patients assigned to perindopril–indapamide therapy, there was a significant but attenuated cumulative benefit with respect to the incidence of death from any cause that extended to the ...

Review the side-effects of Perindopril and Indapamide as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication.

Perindopril and Indapamide(Coversyl Arginine Plus ) generic contains an angiotensin-converting enzyme (ACE) inhibitor and thiazide diuretic, prescribed for high blood pressure.

A fixed combination of perindopril (an ACE inhibitor) plus indapamide (a diuretic), available under the brand name Preterax, was evaluated in a randomized trial ( Lancet. 2007;370:829-840).

REGISTER for free or LOG IN to view this content ...

Cite this article Giles, T. A fixed combination of perindopril and indapamide reduces the risk of vascular outcomes in type 2 diabetes mellitus. Nat Rev Endocrinol 4, 254–255 (2008). https://doi ...